Top

Osteoporosis International

Published in:

01-01-2010 | Original Article

The effect of telomere length, a marker of biological aging, on bone mineral density in elderly population

Authors: N. L. S. Tang, J. Woo, E. W. C. Suen, C. D. Liao, J. C. S. Leung, P. C. Leung

Published in: Osteoporosis International | Issue 1/2010

Abstract

Summary

Telomere length (TL), as a reflection of aging and inflammatory processes, may be associated with bone mineral density (BMD). This study examines the association between TL and BMD cross-sectionally and the rate of bone loss over a 4-year period in 1,867 Chinese elderly community living subjects. After adjusting for confounding factors, no association was observed with BMD or bone loss. The decline in BMD with aging is not reflected by corresponding changes in telomere length.

Introduction

Bone mineral density (BMD) is influenced by the dynamics of aging, inflammatory, and bone remodeling processes. Telomere length (TL) is a reflection of the former two processes and may also be associated with bone loss.

Methods

Hip BMD was measured in 1,867 Chinese elderly community living subjects and the relationship between leukocyte TL measured using quantitative real-time polymerase chain reaction, and bone loss after 4 years was examined.

Results

Women had greater bone loss than men. In women, age of menopause, menarche, estrogen treatment/replacement therapy, and history of previous fracture were also among the significant covariates. However, in multivariate analyses, TL was not associated with BMD in either sex.

Conclusions

TL was not associated with either baseline BMD or bone loss over 4 years and accounted for less than 1.6% of the baseline BMD.

Vogel T, Bitterling H, Dobler T et al (2006) Contemporary diagnostics and therapy of osteoporosis. Zentralbl Chir 131:401–406CrossRefPubMed

Meunier PJ, Delmas PD, Eastell R et al (1999) Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 21:1025–1044CrossRefPubMed

Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMed

Cauley JA, Hochberg MC, Lui LY et al (2007) Long-term risk of incident vertebral fractures. JAMA 298:2761–2767CrossRefPubMed

Gnudi S, Sitta E, Fiumi N (2007) Bone density and geometry in assessing hip fracture risk in post-menopausal women. Br J Radiol 80:893–897CrossRefPubMed

Cauley JA, Lui LY, Barnes D et al (2008) Successful skeletal aging: a marker of low fracture risk and longevity. The study of osteoporotic fractures (SOF). J Bone Miner Res 24(1):134–143CrossRef

Leslie WD, Tsang JF, Lix LM (2008) Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program. Bone 43:667–671CrossRefPubMed

Papaioannou A, Kennedy CC, Cranney A et al (2008) Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 20:507–518CrossRefPubMed

Aviv A, Levy D, Mangel M (2003) Growth, telomere dynamics and successful and unsuccessful human aging. Mech Ageing Dev 124:829–837CrossRefPubMed

10.

Martens UM, Chavez EA, Poon SSS et al (2000) Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res 256:291–299CrossRefPubMed

11.

Murnane JP, Sabatier L (2004) Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26:1164–1174CrossRefPubMed

12.

Pignolo RJ, Suda RK, McMillan EA et al (2008) Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell 7:23–31CrossRefPubMed

13.

Goronzy JJ, Fujii H, Weyand CM (2006) Telomeres, immune aging and autoimmunity. Exp Gerontol 41:246–251CrossRefPubMed

14.

van der Harst P, van der Steege G, de Boer RA et al (2007) Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 49:1459–1464CrossRefPubMed

15.

Magana JJ, Gomez R, Cisneros B et al (2008) Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican women. Arch Med Res 39:618–624CrossRefPubMed

16.

Perez A, Ulla M, Garcia B et al (2008) Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women. J Bone Miner Metab 26:358–365CrossRefPubMed

17.

Styrkarsdottir U, Halldorsson BV, Gretarsdottir S et al (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355–2365CrossRefPubMed

18.

Tran BN, Nguyen ND, Eisman JA et al (2008) Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis. BMC Med Genet 9:55CrossRefPubMed

19.

Kiel DP, Demissie S, Dupuis J et al (2007) Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8(Suppl 1):S14CrossRefPubMed

20.

Richards JB, Rivadeneira F, Inouye M et al (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371:1505–1512CrossRefPubMed

21.

Takayanagi H, Sato K, Takaoka A et al (2005) Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208:181–193CrossRefPubMed

22.

Almeida M, Han L, Martin-Millan M et al (2007) Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282:27285–27297CrossRefPubMed

23.

Sanchez-Rodriguez MA, Ruiz-Ramos M, Correa-Munoz E et al (2007) Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 8:124CrossRefPubMed

24.

Altindag O, Erel O, Soran N et al (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 28:317–321CrossRefPubMed

25.

Bekaert S, Van Pottelbergh I, De Meyer T et al (2005) Telomere length versus hormonal and bone mineral status in healthy elderly men. Mech Ageing Dev 126:1115–1122CrossRefPubMed

26.

Valdes AM, Richards JB, Gardner JP et al (2007) Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 18:1203–1210CrossRefPubMed

27.

Woo J, Tang NL, Suen E et al (2008) Telomeres and frailty. Mech Ageing Dev 129:642–648CrossRefPubMed

28.

Lau EM, Chan HH, Woo J et al (1996) Normal ranges for vertebral height ratios and prevalence of vertebral fracture in Hong Kong Chinese: a comparison with American Caucasians. J Bone Miner Res 11:1364–1368PubMedCrossRef

29.

Washburn RA, Smith KW, Jette AM et al (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162CrossRefPubMed

30.

Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47CrossRefPubMed

31.

Gil ME, Coetzer TL (2004) Real-time quantitative PCR of telomere length. Mol Biotechnol 27:169–172CrossRefPubMed

32.

Norwood D, Dimitrov DS (1998) Sensitive method for measuring telomere lengths by quantifying telomeric DNA content of whole cells. Biotechniques 25:1040–1045PubMed

33.

Baird DM (2005) New developments in telomere length analysis. Exp Gerontol 40:363–368CrossRefPubMed

34.

Gardner JP, Kimura M, Chai W et al (2007) Telomere dynamics in macaques and humans. J Gerontol A Biol Sci Med Sci 62:367–374PubMed

35.

Strike PW (1991) Statistical methods in laboratory medicine. Chapter 8.9. Measurement and control-precision. Butterworth-Heinemann, Oxford. pp. 273-276.

36.

Ho AY, Kung AW (2005) Determinants of peak bone mineral density and bone area in young women. J Bone Miner Metab 23:470–475CrossRefPubMed

37.

Brouilette SW, Moore JS, McMahon AD et al (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369:107–114CrossRefPubMed

38.

Cherkas LF, Hunkin JL, Kato BS et al (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 168:154–158CrossRefPubMed

39.

Aviv A (2008) The epidemiology of human telomeres: faults and promises. J Gerontol Med Sci 63A:979–983

40.

Lau EMC, Choy DT, Li M, Woo J, Chung T, Sham A (2004) The relationship between COLIA 1 polymorphisms (SP I) and COLIA 2 Polymorphisms (ECO R1 and Puv II) with bone mineral density in Chinese men and women. Calcif Tissue Int 75:133–137CrossRefPubMed

41.

Li M, Lau EMC, Woo J (2004) Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women. Bone 35:1369–1374CrossRefPubMed

Title: The effect of telomere length, a marker of biological aging, on bone mineral density in elderly population
Authors: N. L. S. Tang
J. Woo
E. W. C. Suen
C. D. Liao
J. C. S. Leung
P. C. Leung
Publication date: 01-01-2010
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 1/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-009-0948-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The effect of telomere length, a marker of biological aging, on bone mineral density in elderly population

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2010

Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women

The effects of exercise and physical activity participation on bone mass and geometry in postmenopausal women: a systematic review of pQCT studies

A longitudinal Raman microspectroscopic study of osteoporosis induced by spinal cord injury

Raloxifene enhances spontaneous microaggregation of platelets through upregulation of p44/p42 MAP kinase: a case report

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis

Hip protectors: recommendations for conducting clinical trials—an international consensus statement (part II)